Literature DB >> 25010661

MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1.

Hang He1, Si-Jie Hao1, Lie Yao1, Feng Yang1, Yang Di1, Ji Li1, Yong-Jian Jiang1, Chen Jin1, De-Liang Fu1.   

Abstract

miRNA-218 is a highlighted tumor suppressor and its underlying role in tumor progression is still unknown. Here, we restored the expression of miRNA-218 in pancreatic cancer to clarify the function and potent downstream pathway of miRNA-218. The expressions of both miRNA-218 and its potent target gene ROBO1 were revealed by RT-PCR and western blotting analysis. Transfection of miRNA-218 precursor mimics and luciferase assay were performed to elucidate the regulation mechanism between miRNA-218 and ROBO1. Cells, stably expressing miRNA-218 followed by forced expression of mutant ROBO1, were established through co-transfections of both lentivirus vector and plasmid vector. The cell migration and invasion abilities were evaluated by migration assay and invasion assay respectively. An increased expression of ROBO1 was revealed in cell BxPC-3-LN compared with cell BxPC-3. Elevated expression of miRNA-218 would suppress the expression of ROBO1 via complementary binding to a specific region within 3'UTR of ROBO1 mRNA (sites 971-978) in pancreatic cancer cells. Stably restoring the expression of miRNA-218 in pancreatic cancer significantly downregulated the expression of ROBO1 and effectively inhibited cell migration and invasion. Forced expression of mutant ROBO1 could reverse the repression effects of miRNA-218 on cell migration and invasion. Consequently, miRNA-218 acted as a tumor suppressor in pancreatic cancer by inhibiting cell invasion and migration. ROBO1 was a functional target of miRNA-218's downstream pathway involving in cell invasion and migration of pancreatic cancer.

Entities:  

Keywords:  ROBO1; invasion; microRNA-218; migration; pancreatic cancer

Mesh:

Substances:

Year:  2014        PMID: 25010661      PMCID: PMC4130726          DOI: 10.4161/cbt.29706

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

1.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

2.  The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells.

Authors:  Bernd C Schmid; Günther A Rezniczek; Gerhild Fabjani; Toshiyuki Yoneda; Sepp Leodolter; Robert Zeillinger
Journal:  Breast Cancer Res Treat       Date:  2007-02-01       Impact factor: 4.872

3.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

4.  MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

Authors:  Yanyang Tu; Xingchun Gao; Gang Li; Hualin Fu; Daxiang Cui; Hui Liu; Weilin Jin; Yongsheng Zhang
Journal:  Cancer Res       Date:  2013-08-15       Impact factor: 12.701

5.  Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors.

Authors:  T Kidd; K Brose; K J Mitchell; R D Fetter; M Tessier-Lavigne; C S Goodman; G Tear
Journal:  Cell       Date:  1998-01-23       Impact factor: 41.582

6.  MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Authors:  Takeshi Yamasaki; Naohiko Seki; Hirofumi Yoshino; Toshihiko Itesako; Hideo Hidaka; Yasutoshi Yamada; Shuichi Tatarano; Tomokazu Yonezawa; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

7.  Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity.

Authors:  Biao Wang; Yang Xiao; Bei Bei Ding; Na Zhang; Xiao bin Yuan; Lü Gui; Kai Xian Qian; Shumin Duan; Zhengjun Chen; Yi Rao; Jian Guo Geng
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

8.  Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.

Authors:  Anil Prasad; Zahida Qamri; Jane Wu; Ramesh K Ganju
Journal:  J Leukoc Biol       Date:  2007-06-12       Impact factor: 4.962

9.  Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.

Authors:  Chi Han Li; Ka-Fai To; Joanna Hung-Man Tong; Zhangang Xiao; Tian Xia; Paul B S Lai; Sheung Ching Chow; Yin-Xin Zhu; Stephen L Chan; Victor E Marquez; Yangchao Chen
Journal:  Gastroenterology       Date:  2013-02-07       Impact factor: 22.682

10.  Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.

Authors:  Noriko Yamamoto; Takashi Kinoshita; Nijiro Nohata; Toshihiko Itesako; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Naohiko Seki
Journal:  Int J Oncol       Date:  2013-03-07       Impact factor: 5.650

View more
  15 in total

1.  MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression.

Authors:  Yonghong Wang; Yujun Wei; Haibo Tong; Laizhao Chen; Yimin Fan; Yuchen Ji; Wenqing Jia; Dongkang Liu; Guihuai Wang
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 2.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 3.  Developments in miRNA gene signaling pathways in pancreatic cancer.

Authors:  Christina Vorvis; Marina Koutsioumpa; Dimitrios Iliopoulos
Journal:  Future Oncol       Date:  2016-03-17       Impact factor: 3.404

4.  miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.

Authors:  Hongchao Han; Lisheng Wang; Jie Xu; Aikun Wang
Journal:  Exp Ther Med       Date:  2018-04-10       Impact factor: 2.447

Review 5.  MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.

Authors:  Ganji Purnachandra Nagaraju; Appiya Santharam Madanraj; Sheik Aliya; Balney Rajitha; Olatunji Boladale Alese; Ekamber Kariali; Afroz Alam; Bassel F El-Rayes
Journal:  Tumour Biol       Date:  2015-11-04

Review 6.  Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.

Authors:  Susmita Barman; Iram Fatima; Amar B Singh; Punita Dhawan
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

7.  MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells.

Authors:  Fei Miao; Jinhai Zhu; Yanlin Chen; Nanhong Tang; Xiaoqian Wang; Xiujin Li
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

8.  Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.

Authors:  Kai Qu; Xing Zhang; Ting Lin; Tian Liu; Zhixin Wang; Sushun Liu; Lei Zhou; Jichao Wei; Hulin Chang; Ke Li; Zheng Wang; Chang Liu; Zheng Wu
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 9.  Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.

Authors:  Fujiao Duan; Kaijuan Wang; Liping Dai; Xia Zhao; Yajing Feng; Chunhua Song; Shuli Cui; Chengzeng Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 10.  CAR-NK Cells in the Treatment of Solid Tumors.

Authors:  Ewa Wrona; Maciej Borowiec; Piotr Potemski
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.